Search

everythinglearnresearchcommunity

for

Search:↓

Growth factors are crucial for hair development and could help treat hair diseases.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Spironolactone plus finasteride reduces hirsutism more effectively.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Using steroids can increase the risk of heart problems.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.